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Abstract
Most isolates of Toxoplasma from Europe and North America fall into one of three genetically distinct clonal lineages, the
type I, II and III lineages. However, in South America these strains are rarely isolated and instead a great variety of other
strains are found. T. gondii strains differ widely in a number of phenotypes in mice, such as virulence, persistence, oral
infectivity, migratory capacity, induction of cytokine expression and modulation of host gene expression. The outcome of
toxoplasmosis in patients is also variable and we hypothesize that, besides host and environmental factors, the genotype of
the parasite strain plays a major role. The molecular basis for these differences in pathogenesis, especially in strains other
than the clonal lineages, remains largely unexplored. Macrophages play an essential role in the early immune response
against T. gondii and are also the cell type preferentially infected in vivo. To determine if non-canonical Toxoplasma strains
have unique interactions with the host cell, we infected murine macrophages with 29 different Toxoplasma strains,
representing global diversity, and used RNA-sequencing to determine host and parasite transcriptomes. We identified large
differences between strains in the expression level of known parasite effectors and large chromosomal structural variation in
some strains. We also identified novel strain-specifically regulated host pathways, including the regulation of the type I
interferon response by some atypical strains. IFNb production by infected cells was associated with parasite killing,
independent of interferon gamma activation, and dependent on endosomal Toll-like receptors in macrophages and the
cytoplasmic receptor retinoic acid-inducible gene 1 (RIG-I) in fibroblasts.
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Introduction
Toxoplasma gondii is a ubiquitous obligate intracellular protozoan
parasite that can invade and replicate in almost all cells of a wide range
of warm-blooded animals [1]. In humans it is the 2nd most important
foodborne pathogen in terms of annual cost of illness and quality
adjusted life year loss [2]. Normally a lifelong, largely asymptomatic,
infection is established but in immunocompromised individuals and in
congenital infectionsToxoplasma infection can lead to severe disease and
even death. Nevertheless, not all seropositive immunosuppressed
patients have reactivating toxoplasmosis [3], and not all congenital
infections lead to disease [4]. There is good evidence that both the host
genetic background [5–7] and the genotype of the infecting strain [8,9]
play a role in the severity of disease.
Despite the existence of a sexual phase in its life cycle, which
only occurs in felines, few strains dominate human infections in
Europe and North America. Type II strains dominate in Europe,
while in North America, types 12, II and III account for the
majority of strains isolated from wild-life and patients [9–11].
Genotypes not belonging to these lineages are predominant in
South America [12–14]. A phylogenetic analysis of 956 strains,
using single nucleotide polymorphisms (SNPs) identified in five
loci, clustered these into 15 haplogroups, including type I, II and
III [11,15–17]. Using genome-wide SNPs, it was shown that even
within these haplogroups there is often significant diversity and
many strains did not fit into the 15 proposed haplogroups. Instead,
many strains appear to have formed through recent recombination
events [18].
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The relationship between strain genotype and virulence in the
mouse model is well established; type I isolates, and most South
American strains, are highly virulent (LD100 ,1) [19], whereas
type II and III strains are less virulent, with LD50 of,103 and 105,
respectively [20]. Toxoplasma invasion and modulation of its host
cell is mediated by proteins secreted from three secretory
organelles, called micronemes, rhoptries and dense granules
[21]. Using crosses between type I, II and III it was determined
that strain differences in virulence in mice can be largely explained
by the exact allelic combination of the Toxoplasma ROP18 and
ROP5 genes [19,20,22–25]. ROP18 and ROP5 are a secreted
rhoptry kinase and pseudokinase, respectively, that cooperatively
inhibit the murine IFNc-induced immunity-related GTPases
(IRGs) [26–29]. These IRGs can vesiculate the parasitophorous
vacuole membrane (PVM) which ultimately leads to the destruc-
tion of the parasite inside [30]. Toxoplasma polymorphic secreted
effectors that modulate host immune signaling pathways also play
a role in the differences in virulence between type I, II and III
strains. For example, the secreted rhoptry kinase ROP16 from
type I and III, but not from type II, is involved in constitutive
activation of the STAT transcription factors [22,31] while the
secreted dense granule protein GRA15, from type II, but not from
type I and III, mediates high levels of NFkB activation [32].
Expression level differences in ROP38, another secreted rhoptry
kinase, mediates strain differences in gene activation along the
MAP kinase pathway [33]. Thus, the precise allelic combination of
Toxoplasma secreted effectors likely determines how distinct
Toxoplasma strains modulate the host immune response. GRA15
and ROP16 effects can be observed in human, mouse and chicken
cells [32,34], suggesting that Toxoplasma effectors that modulate
host cell transcription might have evolved to target conserved host
proteins.
Part of the variability in disease outcome in human infections
may also be tied to strain type. The few severe congenital
toxoplasmosis cases in Europe seem to be caused by atypical
strains (not type I, II or III) [35]. In North America the incidence
of more severe human congenital infections is higher compared to
Europe and this seems to be associated with a higher prevalence of
non-type II strains [9], most likely type 12 strains as these are also
prevalent in North America. North American atypical strains have
also been associated with severe ocular disease in non immuno-
suppressed patients [36]. In South America, where Toxoplasma
strain diversity is high, congenital and ocular toxoplasmosis are
more prevalent compared to Europe and more often associated
with severe symptoms [4,37]. Some strains from French Guiana
can cause severe disease and even death in non immunosup-
pressed individuals [38–41].
Most of the data currently available on Toxoplasma-host cell
interactions were obtained using the canonical types I, II or III strains,
and little is known about how the atypical strains interact with and
modify host cells. Because these atypical strains are correlated with
more severe disease manifestations, it is important to determine how
they differ from the canonical strains in modulating the host cell. To
identify host cell signaling pathways uniquely modulated by atypical
Toxoplasma strains we infected macrophages with 29 different strains,
representing world-wide diversity, and obtained global transcriptional
profiles of both the host and parasites. The parasite transcriptomes
showed large differences in gene expression, including expression of
host effectors, which correlated with differences in expression of
transcriptional regulators such as the Apetala-2 (AP2) factors.
Combining genome and transcriptome data also identified that some
strains had large structural variations that had an impact on gene
expression levels. Analysis of the host cell transcriptomes revealed
activation of several signaling pathways in a strain-specific manner. For
example, only a few atypical strains induce macrophage type I
interferon production, which was associated with parasite killing,
independent of interferon gamma, that leads to the release of parasite
ligands that trigger intracellular Toll-like receptors and cytoplasmic
nucleic acid sensors. This resource provides insight into the host
response to a large variety of Toxoplasma strains and, together with the
SNPs dataset we recently published for these strains [18], can form the
basis for the discovery of novel Toxoplasma effectors.
Results
Co-regulated host and parasite gene clusters are
enriched in functional annotation
We used RNA-sequencing (RNA-seq) of poly-adenylated RNA,
obtained after infection of primary murine bone-marrow derived
macrophages with 29 different Toxoplasma strains for 20 h, to
capture the mouse and Toxoplasma transcriptomes. We detected
51% (13,179) of murine genes and 93% (8,138) of Toxoplasma genes
(RPKM.1 in at least 1 sample) (Table S1 available online).
Overall Toxoplasma induced macrophage gene expression corre-
lated well with Affymetrix microarrays performed on these cells
with some of the same strains (Protocols S1–2) but with
significantly more genes detected by RNA-seq and a larger
dynamic range (Figure S1). We focused on 2,451 differentially
expressed Toxoplasma (RPKM.10 in at least 1 sample and at least
4-fold different between 2 samples) and 5,016 differentially
regulated host genes (RPKM.5 in at least 1 sample and at least
2-fold different between any 2 samples). To identify co-regulated
host and parasite genes we clustered the macrophage and parasite
gene expression profiles and also clustered the experiments
(strains) to identify parasite strains that modulate host gene
expression similarly or that have similar parasite gene expression
profiles. Clustering the macrophage and parasite expression data
independently into 9–13 major clusters each adequately parti-
tioned the data into co-regulated gene clusters (Figure 1; Figures
S2, S3). Most clusters had significant functional enrichment in
biological processes and the promoters of the genes in the clusters
Author Summary
Toxoplasmosis is caused by the protozoan parasite
Toxoplasma gondii. The parasite is found throughout the
world. When humans are infected, few have symptoms
because a healthy immune system usually prevents the
parasite from causing illness. Nevertheless, cases of severe
disease in otherwise healthy individuals have been
observed. These cases are usually a result of infection
with less common atypical strains of Toxoplasma. Factors
associated with virulence in the atypical strains are not
well understood. Here, we infected host cells with 29
different strains of Toxoplasma, and performed high-
throughput RNA sequencing of both host cells and
parasites. We found significant differences in gene
expression profiles between strains. Host cell transcrip-
tional response also varied substantially depending on the
infecting strain. Specifically, we found that a small group of
atypical strains are able to induce production of type I
interferons, which are immunomodulatory cytokines.
Interferon production is a result of the elimination of
internalized parasites through a novel killing mechanism.
The dataset we generated is a valuable tool for identifi-
cation of host cell targets of Toxoplasma secreted effectors
and can contribute to our understanding of why certain
Toxoplasma strains are more prone to cause severe disease
in humans.
T. gondii Strain-Specific Modulation of Host Cells
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were significantly enriched for transcription factor binding sites
(TFBS) indicating that these clusters represent differential modu-
lation of host/parasite signaling pathways by the different
Toxoplasma strains. The induction of host genes in some clusters
correlated with strain type: for example, cluster 1 is induced by all
type 12 strains, cluster 5 is mainly induced by type II strains or
strains that have part of the type II genome and cluster 7 and 9 by
type 6 strains, possibly indicating host cells responding to genetic
differences between strain types. Genes in the other clusters were
differently regulated by strains of the same clonal haplogroup (e.g,
ME49 and DEG for cluster 6 and 8) possibly indicating host cells
responding to epigenetic differences between strains.
Multiple factors determine gene expression differences
among Toxoplasma strains
Gene expression differences among the Toxoplasma strains could
have multiple causes. For instance, the specific host cellular state
can influence Toxoplasma gene expression [42] and Toxoplasma
secreted effectors could modulate host gene expression resulting in
an altered host cell environment to which it subsequently
responds. Indeed we detected strong correlations between some
host and Toxoplasma gene expression clusters (Table S2). For
example, host gene cluster 6 and 8, which are negatively correlated
(R=20.93), have a significant negative (R=20.86) and positive
(R=0.85) correlation with Toxoplasma gene cluster 1, respectively
(Figure 1C). Host cluster 6 was enriched for genes and pathways
that were previously shown to be modulated in human fibroblasts
by the Toxoplasma secreted kinase ROP38 (Figure 1) [33]. Roos
and colleagues have shown that ROP38 overexpression has a
profound effect on host cell gene expression and modulates host
genes enriched in mitochondrial function, metabolic processes and
proteasome function and genes modulated by ELK1 [33], a
transcriptional activator belonging to the ternary complex factor
(Tcf) family. This is consistent with the functional enrichments
seen for cluster 6, suggesting that this cluster might be regulated by
strain differences in ROP38 expression and that Toxoplasma might
be subsequently responding to the different environment
Figure 1. Transcriptome analysis of host cells infected with 29 Toxoplasma strains reveals clusters of co-regulated genes enriched in
functional annotation. (A–B) Representative heat maps are shown of differentially expressed mouse (A) or Toxoplasma gene clusters (B). Results of
the analysis of enrichment in functional annotation using DiRE, GSEA, and Ingenuity Pathway Analysis are shown. (C) Example of clusters of co-
regulated mouse genes that display high correlation with a cluster of Toxoplasma co-regulated genes. Other clusters are in Figures S2, S3 and details
of the genes present in each cluster can be found in Table S1.
doi:10.1371/journal.ppat.1003779.g001
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established by ROP38. Consistent with this notion the expression level
of ROP38 is highly variable among Toxoplasma strains ranging from low
expression in RH (RPKM=1.1) to extremely high expression in CEP
(RPKM=505) and positively correlates with cluster 6 (R=0.49) and
negatively correlates with cluster 9 (R=20.51).
Differences in expression levels of Toxoplasma transcription
factors could also affect a large number of genes. To determine the
putative Toxoplasma regulators that could modulate the gene
expression clusters we used Genomica [43], which takes a set of
putative regulators (Table S1) and assumes that regulators are
themselves transcriptionally regulated, so that their expression
profiles provide information about their activity level. Although
there are many exceptions to this assumption (e.g. activation by
phosphorylation of signaling transducers, nuclear translocation of
transcription factors upon activation or activation by non-variable
polymorphic transcriptional factors), the expression level of
specific AP2 factors, which are known to be involved in Toxoplasma
gene expression, correlated highly with the expression of
Toxoplasma genes in different clusters. For example Toxoplasma
cluster 5 and 6 are enriched in genes expressed in the bradyzoite
stage and each of these clusters correlate highly with AP2 factors
that are known to be upregulated during bradyzoite development
[44] (AP2X-10 and AP2Ib-1 for cluster 5 and AP2IX-1 and AP2-
IX-9 for cluster 6, Figures 1B; S3 and Table S1). Other non-AP2
putative Toxoplasma gene expression regulators were better
predictors of the expression levels of Toxoplasma genes in different
clusters (Table S1).
To identify potential large structural variations that also might
influence Toxoplasma gene expression levels we made genome-wide
graphs of the relative gene expression values for each strain against
the position on the genome. This revealed that BOF, B73 and
TgCatBr44 each had a large genomic region with on average
twice the median expression value (Figure 2A; BOF [chrVIIb; 2.1–
2.75 Mb and 3.2–3.52 Mb], B73 [chrX; 5.5–6.2] and TgCatBr44
[chrIX; 0.3–1.28 Mb and 1.7–3.2 Mb]), suggesting a large
duplication. We previously sequenced the genome of BOF [18]
and we used this data to confirm the putative structural variation
identified using relative gene expression levels. To do this we
plotted the relative number of reads mapped to chrVIIb averaged
over 15 kb intervals. Indeed this identified two regions (2.1–2.75
and 3.2–3.52 Mb) on BOF chrVIIb that have on average twice as
many reads compared to the rest of the chromosome and are
therefore likely duplicated (Figure 2B). No such duplicated regions
were detected in GPHT and FOU, even though these strains are
highly related to BOF [18] and together constitute the clonal type
6 haplogroup, showing that even within a clonal lineage there can
be significant variation leading to differences in gene expression
levels.
Allelic and expression differences in the GRA15 gene
determine strain differences in NFkB activation
Mouse gene expression cluster 5 contained 459 genes that were
mainly upregulated in cells infected with type II (ME49, DEG and
PRU), B41 and B73 strains (Figure 1A). Functional enrichment
analysis showed that this cluster was enriched in genes activated by
NFkB transcription factors (NFkB1, RelA) and pathway analysis
also indicated enrichment in pathways consistent with NFkB
activation. Type II, but not type I/III, strains strongly activate
NFkB-dependent gene expression, which is due to the polymor-
phic secreted dense granule protein GRA15 [32]. Indeed, genes in
cluster 5 were also highly enriched in genes that are upregulated
by GRA15. To investigate the upregulation of NFkB regulated
genes and strain type further we sequenced GRA15 from all strains
used in this study. This showed that type II, B41 and B73 strains
share the same GRA15 allele (GRA15II), which is shorter than the
other alleles because of a 255 bp deletion (Figure S4 and S5). As
expected, activation and translocation of the NFkB p65 subunit to
the host cell nucleus can only be observed in cells infected with
parasites strains expressing GRA15II, and is abolished in type II
parasites in which GRA15 gene was knocked out (Figure S6).
Nevertheless, we observed that several atypical strains, for
example VAND, RAY, WTD3, GUY-KOE, P89, CASTELLS
and COUGAR, all of which express a full length copy of GRA15,
were also able to induce a less intense but significant NFkB
response (Figure 1A), suggesting that other parasite factor(s) may
play a role in controlling NFkB activation. To further investigate
this, we infected an reporter cell line expressing a luciferase gene
under the control of NFkB transcription factor response elements
with the different T. gondii strains and observed that strains with
higher expression of GRA15, including VAND, WTD3, RAY and
GUY-KOE, induced higher activation of the reporter regardless of
the GRA15 allele they express (Pearson correlation between
GRA15 expression level and luciferase activity = 0.7, Figure 3A).
The exception was RH, which expresses a truncated non-
functional form of GRA15 due to a premature stop codon [32].
This suggests that expression levels of GRA15 may also be
significant in controlling NFkB activation. To test this hypothesis
we designed transgenic RH parasites overexpressing either the
type II (58 kDa) or type III (66 kDa) GRA15. Levels of transgenic
expression of GRA15 were similar in both parasites (Figure 3B).
Figure 2. Genome-wide expression analysis uncovers strain-
specific structural variations in Toxoplasma. (A) Average relative
gene expression of strains TgCATBr44, BOF and B73, as calculated by
dividing that strain’s gene expression by the median gene expression of
all strains, plotted against the position in chromosomes VIIb, IX and X.
(B) Relative number of reads obtained from BOF sequenced genome
and mapped to ChrVIIb averaged over 15 kb intervals plotted against
chromosomal positions.
doi:10.1371/journal.ppat.1003779.g002
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Using immunofluorescence analysis of infected human foreskin
fibroblasts we observed that transgenic overexpression of the type
III copy of GRA15 in RH parasites also leads to efficient NFkB
activation (Figure 3C). Still, not all strains with high expression
levels of GRA15 (e.g. BOF) induced a strong pro-inflammatory
response (Figure 1A) or are able to induce nuclear translocation of
NFkB subunit p65 (Figure S6). Taken together, our data suggest
that although GRA15II is the main activator of NFkB, high
expression levels of different GRA15 alleles can also induce pro-
inflammatory responses in infected host cells, possibly through
activation of different NFkB subunits.
The host cell pro-inflammatory response is modulated by
multiple Toxoplasma secreted factors
We have previously shown that GRA15 induction of an NFkB-
dependent pro-inflammatory response can be antagonized by the
activity of Toxoplasma polymorphic rhoptry kinase ROP16 [45].
Recently, ROP38, a rhoptry protein that is highly expressed in
type III parasites relative to types I/II, was shown to downregulate
several host cell responses, including cytokine production, induced
during infection [33]. Indeed, we observed that ROP38 expression
was highly variable in the different strains, with the highest
expression observed in the type III strain CEP (Figure 4A). We
Figure 3. Toxoplasma NFkB activation depends on both the expression levels and specific allele of dense granule protein GRA15. (A)
Top: GRA15 gene expression levels as determined by high-throughput RNA sequencing. Bottom: Indicated Toxoplasma strains were used to infect
HEK293 cells stably expressing luciferase gene under the control of an NFkB promoter. 20 h post infection luciferase activity was measured in cell
lysates. The relative luciferase activity was calculated by normalizing the raw luminescence values to the background. Data is average of at least three
independent experiments. (B) Western blot on lysates of the indicated strains using an antibody against GRA15 detects the type II GRA15 (58 kDa)
and the type I/III GRA15 (66 kDa). SAG1 antibody was used as parasite loading control. (C–D) Human foreskin fibroblasts where infected with the
indicated strains of T. gondii for 24 hours, fixed and stained with a-NFkB (p65). Levels of nuclear p65 were quantified using NIS-Elements software
(Nikon). NI = non-infected. Data is representative of two independent experiments.
doi:10.1371/journal.ppat.1003779.g003
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previously observed by microarray analysis that CEP expressing
GRA15II induced significantly lower levels of NFkB-regulated
genes compared to type I+GRA15II [32]. We therefore wanted to
test whether ROP38 can dampen pro-inflammatory responses
activated by GRA15II. Indeed, only RH-GRA15II, but not CEP-
GRA15II, induced nuclear translocation of NFkB subunit p65
(Figure 3D) even though both transgenic strains expressed similar
levels of GRA15 (Figure 3B). To test if the higher expression of
ROP38 observed in CEP could be responsible for this phenotype,
we engineered type II (PRU) parasites to overexpress a transgenic
copy of HA-tagged ROP38 (Figure 4B). Compared to the control
type II parasites, activation of the NFkB reporter cell line is
markedly reduced in cells infected with parasites overexpressing
ROP38 (Figure 4C).
We have also previously shown that GRA15II induces and
ROP16I/III represses IL12p40/p70 production by infected mac-
rophages [32,45]. Because NFkB activation is required for IL12
production we wanted to confirm that other genes, besides
GRA15 and ROP16, could play a role in strain differences in IL12
induction. We therefore infected BMDM with F1 progeny derived
from IIxIII crosses that have both type II GRA15 and ROP16
alleles (S25, S27, STE7, D3X1) and assessed production of
IL12p40 and IL12p70. Even though both the S25 and S27 strains
have ROP38 alleles derived from the parental type II strain (data
not shown), only the type II and S27 infection led to the
production of high levels of IL12p70 (Figures 4D–E), indicating
that besides GRA15 and ROP16 other genes play a role in the
strain-specific induction of IL12 secretion. Thus, although
Figure 4. ROP38 inhibits NFkB activation. (A) Expression level of ROP38 in both control parasites (PRUDhpt) and PRU transgenically expressing
ROP38II, as detected by RNA sequencing. (B) Type II (PRU) parasites overexpressing HA-tagged ROP38 were used to infect monolayers of HFFs. After
3 h cells were fixed and stained with anti-HA to detect ROP38 (red), anti-SAG1 to detect parasites and Hoechst to detect parasite nucleus (blue). (C)
HEK293 cells stably expressing luciferase under control of NFkB canonical promoter elements were infected with the indicated strains of Toxoplasma.
20 h post infection luciferase activity was measured in cell lysates. Data depicted is the combination of three independent experiments. (D–E) BMDM
were infected for 24 h with a type II, III and F1 progeny from IIxIII crosses that contained type II GRA15 and ROP16 alleles (S25, S27, STE7, D3X1) and IL-
12p40 (D) and IL12p35 (E) levels were detected in the supernatant using ELISA. Bars = standard error. Similar results were obtained in at least two
independent experiments.
doi:10.1371/journal.ppat.1003779.g004
T. gondii Strain-Specific Modulation of Host Cells
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GRA15II is the main parasite factor controlling NFkB-dependent
host cell responses, the expression level of other GRA15 alleles and
other Toxoplasma secreted proteins, including ROP16 and ROP38,
also affect host cell inflammatory responses. This is reflected in
mouse expression clusters 7 and 9, which contain genes that are
mainly induced by strains that do not activate a strong
inflammatory response (type 6, RH, CAST and CEP).
Effector sequence versus activity correlations can
pinpoint critical residues that determine strain
differences in activity
Once a Toxoplasma effector that modulates strain-specific
regulation of host signaling pathways is identified it is often
unclear what exactly determines the strain specificity of that
activity. For example type I, II and III all have similar expression
levels of the polymorphic rhoptry kinase ROP16 but only ROP16
from types I and III constitutively activate STAT3 and STAT6
[22]. By making chimeric ROP16 from type I and II and
subsequent individual substitutions it was determined that a single
leucine to serine substitution at position 503 (LRS503) in the
kinase domain of type II ROP16 (ROP16II) is responsible for its
significantly reduced kinase activity for its STAT3 substrate
[22,46,47]. To determine whether data from multiple strains could
have predicted that the LRS503 is the critical difference that
determines strain differences in ROP16 activity we used our RNA-
seq data to assemble the ROP16 allele for each strain, perform
evolutionary analysis (Figures 5A and S7) and determine for each
strain if it could constitutively activate STAT6, a reliable read out
for ROP16 activity. All strains with a non-type II ROP16 allele
constitutively activated STAT5 and STAT6 (Figures S8, S9).
COUGAR, which constitutively activates STAT6, has a ROP16
that only differs at two positions from type II ROP16, it has an
alanine at position 502 and a leucine at 503. Thus, sequence
versus activity correlations of a polymorphic effector using data
from a large collection of strains can directly pinpoint the crucial
residue(s) that mediate the strain differences in the activity of the
effector. We also observed higher rates of non-synonymous/
synonymous (NS/S) polymorphisms at the STAT3-interaction site
[22,46,47] and part of the kinase domains of ROP16 (Figure 5B).
The fact that ROP16 from all non-type II strains is active, with the
exception of B73 (Figures S8, S9, data not shown), which is an F1
from a cross between type II and type III [18], suggests that the
ROP16II LRS mutation is a recent event that occurred after
divergence of type II from the closely related WTD3, B41 and
RAY type 12-like strains.
Toxoplasma atypical strains activate type I interferons
Among the novel pathways we identified, we observed that most
type 12 Toxoplasma strains, and some other atypical strains,
induced a cluster of 543 genes (Cluster 1 in Figure 1) that are
enriched in components of the type I interferon signaling pathway,
including Ifnb1, the family of RNA helicases Ddx58 (RIG-I), Dhx58
(LGP2) and Ifih1 (MDA5), several interferon inducible proteins,
including Ifitm3 and Ifi35, and immunity-related GTPases (IRGs).
Upstream regulator analysis indicated that the Interferon Regu-
latory Factors (IRF1, IRF2, IRF7) were the most likely regulators
of this cluster (Figure 1A). Pathway and network analyses of these
genes also revealed enrichment for genes involved in IFNb
Figure 5. Evolutionary analysis of ROP16. (A) Evolutionary bootstrap consensus tree of ROP16 was inferred from 500 replicates using the
Neighbor-Joining method. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are
shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the
phylogenetic tree. The evolutionary distances were computed using the Poisson correction method and are in the units of the number of amino acid
substitutions per site. Analyses were performed in MEGA5 software. (B) Cumulative behavior, codon by codon, of the average synonymous and non-
synonymous substitutions rates of GRA15 alleles performed using the Synonymous Non-synonymous Analysis Program (SNAP, [83]). STAT3
interacting domain and kinase domain are indicated.
doi:10.1371/journal.ppat.1003779.g005
T. gondii Strain-Specific Modulation of Host Cells
PLOS Pathogens | www.plospathogens.org 7 December 2013 | Volume 9 | Issue 12 | e1003779
signaling (Figures 1A and 6A). Another cluster (Cluster 4)
containing 399 genes had a high negative correlation with the
IFN cluster (R=20.93). This cluster was highly enriched for genes
involved in EIF2 signaling and translation (Figure 1A). It is likely
that type I IFN production led to activation of protein kinase R
(PKR), which can phosphorylate EIF2A and thereby block
translation.
Only a few atypical Toxoplasma strains were capable of inducing
high levels of Ifnb and Rsad2 (an IFNb induced gene also called
viperin) expression, the most potent inducers being RUB and
COUGAR (Figure 6B). To validate our RNA-seq data, we
infected BMDMs with several Toxoplasma strains and measured
interferon beta in the supernatants 24 hours post infection. Both
IFNb protein and IFNb transcripts were produced by cells infected
with COUGAR and RUB, but not other canonical or atypical
strains tested (Figures 6C–D). Time course experiments showed
that IFNb transcripts can be detected as early as 8 h post infection,
peaking at 12 h (Figure 6E and data not shown).
Toxoplasma induction of type I interferon is dependent
on IRF3 and endosomal TLRs or RIG-I
Transcriptional regulation of type I interferons by viral
pathogens depends on the activity of either IRF3 and/or IRF7
[48]. To investigate whether Toxoplasma induction of IFNb was
also dependent on these host cell transcription factors, we infected
immortalized macrophages, derived from wild type or mice
deficient for different IRFs, with the ‘activating’ strain COUGAR.
Ifnb transcription was completely abolished in infected cells lacking
IRF3, but not in cells lacking IRF7 (Figure 6F), showing that the
IRF3 transcription factor is essential for parasite-induced IFNb
production. As expected, single IRF knockout cells were still
responsive to synthetic double stranded DNA poly d(A):d(T), but
cells missing both IRF3 and IRF7 were unresponsive (Figure
S10A). To test which host cell signaling pathway was being used
by atypical Toxoplasma strains to activate IRF3, we infected wild
type, Unc93B1 3 d mutant (which are defective in intracellular
TLR trafficking and activation) or MyD88 and TRIF double
knockout immortalized macrophages with COUGAR and per-
formed qPCR analysis for Rsad2 20 h post infection. Rsad2
transcription was completely abolished in infected MyD88/TRIF
dKO macrophages (Figure 6G) and strongly reduced in 3 d cells,
suggesting that endosomal Toll-like receptors are essential for
parasite-induced IFNb production in macrophages. Importantly,
the absence of TLR signaling did not affect the ability of
macrophages to produce IFNb in response to transfected double
stranded DNA (Figure S10B). Nevertheless, we observed that in
murine fibroblasts, which express much lower levels of TLRs than
macrophages [49], Ifnb transcript levels after both COUGAR
infection or poly d(A):d(T) treatment are dependent on the
cytoplasmic nucleic acid receptor RIG-I (Figure 6H; Figure
S10C). Taken together our data show that IFNb induction by
atypical Toxoplasma strains is dependent on activation of different
nucleic acid sensing pathways depending on host cell type.
Toxoplasma also induces type I interferon production in
human cells
To determine if COUGAR also induced type I IFN production
in human cells we performed transcriptional analysis of HFFs
infected with either canonical or atypical Toxoplasma strains. We
observed that COUGAR could also induce a strong IFNb
signature in human cells, whereas neither the canonical strains
nor atypical strains CASTELLS and MAS did (Figure 7A). Since
we observed that IFNb induction is dependent on activation of
nucleic acid sensors, we hypothesized that strains capable of
inducing IFNb are somehow being destroyed by the host cells,
releasing both parasite DNA and RNA that are then detected by
either TLRs or RLRs. To test this, we infected HFFs monolayers
with a non-activating type II (PRU strain) or the activating
COUGAR strain. As the typical lytic cycle of PRU and
COUGAR takes about 72 hours, we chose 24 h and 48 h time
points to evaluate parasite growth prior to lysis of host cells. Cells
were fixed, stained with antibodies against GRA7 and SAG1 to
visualize both parasite vacuoles and parasites respectively. As
expected, in monolayers infected with PRU, the number of
vacuoles per field remained constant throughout the experiment,
while the number of parasites per vacuole increased due to
parasite division (Figures 7B–C). In cells infected with COUGAR,
we observed a marked reduction in the number of vacuoles per
field, suggesting that the host cells were destroying the vacuoles,
and the increase in number of parasites per vacuole was negligible
(Figures 7B–C).
Previously, we showed that in IFNc-stimulated MEFs, type II
strain vacuoles are rapidly coated with IRGs after which they are
destroyed [28], potentially releasing parasite DNA and RNA into
the host cell cytoplasm. To test if parasite killing can induce the
production of type I IFN, we infected MEFs that were pre-
stimulated with IFNc with a type II strain. Indeed IFNc-
stimulated type II infected cells produced much higher Ifnb levels
compared to IFNc-stimulated or control cells (Figure 7D).
Moreover, transfection of Toxoplasma DNA into host cells was
sufficient to induce the upregulation of the type I IFN induced
gene Rsad2 (Figure 7E).
Our data show that intracellular killing of T. gondii results in the
release of parasite nucleic acids that lead to activation of either
TLR or RLR receptors, triggering a signaling cascade that
activates IRF3 and culminates in the production of IFNb
(Figure 8). This suggests that ‘resting’ cells can eliminate
intracellular parasites through a novel, IFNc-independent killing
mechanism, and some atypical strains of Toxoplasma are more
susceptible to this killing mechanism, resulting in increased
induction of the type I IFN response.
Discussion
In South America both congenital and ocular toxoplasmosis are
more prevalent compared to Europe and more often associated
with severe symptoms [4,37]. There is some evidence that this is
associated with atypical strains (not type I, II or III), mainly
present in South America. Some strains from French Guiana can
cause severe disease and even death in non immunosuppressed
individuals [38–41]. Also in North America atypical (non type I/
II/III) strains have been associated with more severe disease
symptoms [36]. However, it is currently unknown if these atypical
strains differ in their interaction with host cells. Here we provide
the complete murine macrophage and Toxoplasma transcriptomes
after infection with 29 different Toxoplasma strains. We have
identified clusters of co-regulated macrophage and parasite genes
that are enriched for functional annotation. We expect that this
data will form the basis for exploring the molecular basis for the
differential regulation of these gene expression clusters.
As an example we explored a cluster of co-regulated host genes
that are enriched in genes regulated by type I IFN and show that
only a small number of atypical strains activate the type I IFN
response. We show that the type I IFN induction by these strains is
associated with the killing of parasites in non-stimulated cells and
the recognition of DNA/RNA by endosomal and/or cytoplasmic
pattern recognition receptors.
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Figure 6. Strain-specific activation of the type I interferon signaling pathway. (A) Ingenuity network based on the clustered genes is
centered on IFNb. (B) Expression levels of Ifnb (top) and Rsad2 (bottom) in BMDMs infected with the indicated strains of T. gondii for 20 h as
determined by RNA sequencing. (C) Secretion of IFNb protein by BMDMs into culture supernatants after infection with the indicated strains was
detected 24 h post-infection by ELISA. (D) BMDMs were infected with indicated Toxoplasma strains for 24 h, and subsequently qPCR was used to
detect Ifnb1. Relative expression levels were calculated by normalizing against actin expression. (E) BMDMs were infected with COUGAR and RNA
isolated at the indicated time points. qPCR was used to detect Ifnb1. (F–H) Wild-type, IRF3, IRF7 and IRF3/IRF7 knockout immortalized macrophages
(F), Unc93b1 triple-deficient mutant (3 d) and MyD88/TRIF double knockout immortalized macrophages (G), or wild-type and RIG-I knockout MEFs (H)
were infected with COUGAR and qPCR was used to detect Ifnb1, Rsad2 and actin expression levels. Data is representative of three (C–D) or two (E–H)
experiments yielding similar results.
doi:10.1371/journal.ppat.1003779.g006
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The combination of Toxoplasma secreted effectors that leads to
optimal fitness in one host is unlikely to be optimal in all of
Toxoplasma’s hosts and if strains end up in the wrong host they
might cause disease by either causing pathological inflammation or
by overwhelming the host. Indeed, different host species display
large differences in susceptibility to Toxoplasma and different
Toxoplasma strains often differ in virulence in the same host species
suggesting that specific Toxoplasma strains might have adapted to
certain hosts [50–52]. Our data indeed show large differences
between strains in the modulation of host genes. One of the most
consistent observations is the large difference between Toxoplasma
strains in the activation of an inflammatory response. Here we
show that this is mediated by differences in the sequence and
expression level of GRA15, which can activate the pro-inflamma-
tory transcription factor NFkB, and by differences in the activation
of the type I IFN response. Other Toxoplasma effectors, such as the
ROP16 and ROP38 protein kinases, can inhibit this inflammatory
response. Therefore, the exact sequence and expression levels of
GRA15, ROP16 and ROP38, determine the potential of different
Toxoplasma strains to induce inflammation. In general the type II,
type 12 and COUGAR strains are more pro-inflammatory while
type I, type III and type 6 are the least inflammatory. However,
even within clonal haplogroups, large differences in the induction
of host gene expression exist. In North America, non-type II
strains have been associated with more severe toxoplasmosis [9].
Because type 12 strains were recently shown to be prevalent in
North America [11,15–17], it is possible that they are the cause of
severe disease.
It is interesting that our results indicate that type 12, and the
closely related COUGAR strain [18], induce a gene expression
profile enriched for type I IFN signaling. For the COUGAR
strain, that was also confirmed in human cells. Type I interferons
(IFN-a/b) are potent coordinators of antimicrobial responses,
controlling both cell autonomous innate responses and T cells
memory and effector functions [53,54]. Besides their role in viral
infections, they can also play an important role during parasitic
infections by either controlling parasite growth through activation
of intracellular killing mechanisms [55–60] or enhancing severity
of disease caused by Trypanosoma cruzi, Leishmania, and Plasmodium
[61–64]. Importantly, type I interferons can affect infection
persistence [65,66], which depends on both timing and magnitude
of the interferon response [67]. We observed that the exotic strain
Figure 7. Killing of intracellular parasites is associated with IFNb production. (A) Microarray analysis of HFFs shows differentially expressed
host genes belonging to the type I interferon pathway (rows) induced during infection with different T. gondii strains (columns). (B–C) HFFs
monolayers were infected with either PRU or COUGAR parasites for two hours, and subsequently washed to remove extracellular parasites. At the
indicated time points cells were fixed, permeabilized, and stained with anti-SAG1 and anti-GRA7 to visualize parasites and vacuoles respectively.
Number of parasites per cell (B) and vacuoles per field (C) was determined by counting at least 60 infected cells and 5 microscope fields per
condition. Error bars represent standard error. Data is representative of three independent experiments. * = p,0.05. (D) HFFs monolayers where
either pre-treated with IFNc 100 u/ml for 24 hours or left untreated, and subsequently infected with T. gondii (PRU strain). After 20 hours of infection
total RNA was isolated and expresion levels of Ifnb1 was determined by qPCR. Data is representative of experiments done two times. (E) Immortalized
murine macrophages were stimulated overnight with 2.5 mg/ml of T. gondii genomic DNA or Poly(dA:dT) either naked or conjugated with
transfection reagents that delivers nucleic acids to the cytoplasm (X-tremeGENE9) or endosomal compartments (DOTAP). Subsequently total RNA was
isolated and expression levels of Ifnb1 was determined by qPCR. Data is representative of two independent experiments.
doi:10.1371/journal.ppat.1003779.g007
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Figure 8. Schematic model depicting induction of type I interferons by Toxoplasma. Most parasite strains, when infecting resting, non-
stimulated host cells, establish themselves in a parasitophorous vacuole that is permissive to parasite growth and do not induce IFNb. Nevertheless,
some atypical strains, like COUGAR and RUB, are killed right after formation of the parasitophorous vacuole, releasing parasite nucleic acid that can be
captured by autophagossomes or released into the host cell cytoplasm, where it can interact with either Toll-like receptors or RIG-I-like receptors
resulting in production of IFNb.
doi:10.1371/journal.ppat.1003779.g008
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COUGAR, is more susceptible than type II strains to IFNc-
independent killing, which leads to an early IFNb production. This
strain specific difference in timing and magnitude of type I interferon
response may result in different disease outcomes. We have observed
that expression of type I interferons by infected host cells is followed by
induction of IRGs, which have a major role in controlling parasite
growth [30]. Indeed, it has been previously shown that IFNb can
control Toxoplasma growth both in vitro and in vivo [68,69]. Nevertheless,
these studies were performed by pre-treating cells or animals with high
doses of recombinant IFNb, and lack an assessment of the role of type I
interferons in physiological conditions. In this regard, type II strains of
Toxoplasma were shown to stimulate type I interferon production in vivo
by intestinal cells following oral infection with T. gondii cysts [70,71],
however no detailed analysis of the role of this cytokine in disease
progression has been performed. Thus, even though induction of IFNb
could potentially be beneficial for the host by controlling intracellular
parasite growth, it is striking that in the mouse model COUGAR
parasites are significantly more virulent than type II strains [19]. It is
currently unclear if this enhanced virulence was due to increased
parasite burden or enhanced pathogenesis possibly due to a strong pro-
inflammatory response. Because COUGAR is genetically quite
different from the type II strain [18] it is possible that its enhanced
virulence is unrelated to its induction of IFNb and due to differences in
other polymorphic effectors. However, in the context of recent
observations that type I IFN suppresses type II IFN-triggered human
anti-mycobacterial responses [72] it is plausible that the type I IFN
response induced by some of the Toxoplasma strains could be associated
with increased pathogenesis in human patients.
The simultaneous capture of both the parasite and host
transcriptomes has also provided us with important insights into
the crosstalk between the host and the parasite. We observed
significant correlations between the expression of Toxoplasma and
host gene clusters. It has been previously observed that the state of
the host cell can modulate Toxoplasma gene expression. For
example addition of compound 1 to host cells induces differen-
tiation of Toxoplasma into bradyzoites and the knockdown of
CDA1, a nucleosome assembly-related protein, demonstrated its
involvement in cell cycle arrest and negative control of cell
proliferation, mimicking the effects of compound 1 [42]. A
potential role for the host cell cycle state in modulating Toxoplasma
growth and differentiation has also been observed by others, for
example, Toxoplasma spontaneously differentiates into bradyzoites
upon invasion of terminally differentiated skeletal muscle and
neuronal cells [73,74]. Recently it was shown that the dense
granule protein GRA16 is secreted beyond the PVM and traffics
to the host cell nucleus [75], where it could potentially regulate
host cell cycle. It was suggested that GRA16 downregulation of
cyclin-B1 could be the main cause of the GRA16-induced G2
arrest, which has also been observed by others to be associated
with Toxoplasma infection [76,77]. Many of our strain-specifically
regulated host gene clusters are also enriched for processes
involved in cell cycle regulation suggesting that this is an important
target for Toxoplasma effectors. For example host expression cluster
9 is enriched for host genes modulated by P53 and the CDKN1A
kinase. It is also enriched in genes involved in regulation of the
host cell cycle, especially G2/M checkpoint regulation. Because
these are highly similar to the processes regulated by GRA16 it is
tempting to speculate that strain differences in expression of
GRA16 and/or sequence of GRA16 might be involved. All
together, our study provides global insight of host cells and parasite
transcriptional responses upon infection with both canonical and
exotic Toxoplasma strains, and allows identification of novel strain
specific host cell responses and parasite effectors.
Materials and Methods
Ethics statement
All experiments involving animals were in accordance with
guidelines set forth by the American Association for Laboratory
Animal Science (AALAS). All protocols used in this work were
approved by the Committee on Animal Care (CAC #0611-063-
14) at the Massachusetts Institute of Technology.
Reagents
All tissue culture reagents were obtained from Gibco, unless
otherwise indicated. Poly(dA:dT) was obtained from Invivogen. All
oligonucleotide primers were obtained from Integrated DNA
Technologies.
Mice
C57BL/6J mice were obtained from The Jackson Laboratory.
Female, 6–12 weeks old mice were used in all experiments. Mice
were housed under specific pathogen free conditions at Massa-
chusetts Institute of Technology animal facility.
Parasites
Toxoplasma was cultured on human foreskin fibroblasts as
described previously [32]. The following Toxoplasma strains, with
the animal and country it was originally isolated from in brackets,
were used in this study: ARI (human, USA), B41 (bear, USA), B73
(bear, USA), BOF (human, Belgium), CAST (human, USA),
CASTELLS (sheep, Uruguay), CEP (cat, USA), COUGAR
(Cougar, Canada), DEG (human, France), FOU (human, France),
GPHT (human, France), GT1 (goat, USA), GUY-DOS (human,
French Guiana), GUY-KOE (human, French Guiana), GUY-
MAT (human, French Guiana), MAS (human, France), ME49
(sheep, USA), P89 (pig, USA), PRU (human, France), RAY
(human, USA), RH (human, USA), ROD (human, USA), RUB
(human, French Guiana), TgCatBr5 (cat, Brazil), TgCatBr9 (cat,
Brazil), TgCatBr44 (cat, Brazil), VAND (human, French Guiana),
VEG (human, USA), WTD3 (white-tailed deer, USA) [16]. The
genetic relationship among these strains was previously investigat-
ed using genome-wide SNP data [18]. Strains originating from
France and French Guiana were provided by the BCR
Toxoplasma (http://www.toxocrb.com). To generate PRU
(DHXGPRT) parasites expressing the type II allele of ROP38,
the ROP38 coding region and putative promoter region (1,437 bp
upstream of the start codon) were amplified from PRU genomic
DNA by PCR (forward, 59-CGAGAGGGAAGCAACGTTTA-
39, reverse, 59-TTACGCGTAGTCCGGGACGTCGTACGGG-
TAAAATTGATGCGTTCTTATCCGACG-39). Sequence cod-
ing for a C terminal HA tag was included in the reverse primer
(denoted with italics). ROP38IIHA was then cloned into pTKO-att
[32] through LR recombination. The pTKO-att-ROP38IIHA
vector was then linearized with NotI (New England Biolabs, Inc.)
and transfected into PRUDHXGPRT by electroporation. Stable
integrants were selected in media with 50 mg/ml mycophenolic
acid (Axxora) and 50 mg/ml xanthine (Alfa Aesar) and cloned by
limiting dilution. Immunofluorescence was used to confirm
expression of ROP38II via anti-HA staining. All parasite strains
and cell lines were routinely checked for Mycoplasma contamination
and it was never detected.
Cells
RIG-I knockout mouse embryonic fibroblasts (MEFs), IRF3,
IRF7 and IRF3/7 knockout immortalized mouse macrophages
were provided by Katherine Fitzgerald (UMass Medical School).
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Immortalized macrophages expressing a mutant, non-functional
form of Unc93B1, and MyD88/TRIF double-knockout macro-
phages were provided by Douglas T. Golenbock (UMass Medical
School). Human foreskin fibroblasts (HFFs) and MEFs were
maintained in DMEM medium supplemented with 10 mM
Hepes, 100 U/ml Penicillin-Streptomycin and 10% FCS (PAA
Laboratories). Immortalized macrophages were kept in DMEM
supplemented with 10 mM Hepes, 100 U/ml Penicillin-Strepto-
mycin, 1 mM Pyruvate, 10% L929 supernatant and 10% FCS.
Bone marrow-derived macrophages infection and RNA
isolation
Bone marrow-derived macrophages (BMDMs) were isolated as
described [78], and were cultured in RPMI medium supplemented
with 25 mM Hepes, 10 mM L-glutamine, 100 U/ml Penicillin-
Streptomycin, 50 mM 2-mercaptoethanol and 10% FCS. BMDMs
were seeded in 6 well plates at 70% confluency and infected with
different strains of T. gondii at three multiplicity of infections
(MOIs): 15, 10 and 7.5. At the same time a plaque assay was setup
to determine the viability and real MOI of each strain. After 20 h,
total RNA was isolated using the RNeasy Plus kit from Qiagen,
according to the manufacturer instructions. RNA integrity, size
and concentration were verified using the Agilent 2100 Bioana-
lyzer and samples with similar Toxoplasma infections rates as judged
by the Toxoplasma ribosomal band (Figure S11) were selected for
RNA-seq.
High-throughput RNA sequencing
The RNA was processed for high-throughput sequencing
according to standard Illumina protocols. Briefly, after mRNA
pull down from total RNA using Dynabeads mRNA Purification
Kit (Invitrogen), mRNA was fragmented into 200–400 base pair-
long fragments and reverse transcribed to cDNA. Illumina
sequencing adapters were added to each end, and samples were
barcoded and multiplexed (four samples per lane) for sequencing
on the Illumina HiSeq 2000 machine. On average 68 million
40 bp reads were obtained from each library. Reads in fastq
format were mapped to either mouse (build 37.2) or Toxoplasma
gondii (strain ME49, version 8.0) genomes using Bowtie 2.0.0 and
Tophat 2.0.4. [79]. Transcripts from each sample were assembled,
merged, and their expression values in FPKM were calculated
using the Cufflinks package, version 2.0.2. [79]. Detailed
methodology can be found in the supplemental material, and
settings used are included in Table S3A–B.
Clustering and functional annotation of Toxoplasma
gondii strains and infected host cells transcriptome
To identify host signaling pathways modulated by Toxoplasma in
a strain-specific manner we specifically focused on macrophage
genes that had at least a 2-fold difference in expression between
macrophages infected with different Toxoplasma strains and had
FPKM$5 in at least 1 strain. To identify differentially regulated
Toxoplasma gene clusters we specifically focused on Toxoplasma
genes that had at least a 4-fold difference in expression between
any two different Toxoplasma strains and had at least a FPKM value
of 10 in one strain. We used Genomica [43] to cluster the genes
into 10–15 clusters of co-regulated genes. These clusters were then
investigated for enrichment for functional annotation, such as
enrichment for transcription factor binding sites (TFBS) in their
promoters or belonging to a particular pathway using DiRE [80],
GSEA [81], and Ingenuity Pathway Analysis (www.ingenuity.
com). A more detailed explanation of data analysis can be found in
the supplemental methods online (Protocols S1–2).
Identification of structural variation using gene
expression levels
We first identified all Toxoplasma protein coding genes with a
median expression of .7.5 and subsequently determined the
relative expression for each gene for each Toxoplasma strain by
dividing the gene expression values, for each strain, by the median
gene expression of all strains. We then made genome-wide graphs
of these relative expression values for each strain by plotting the
average relative expression in steps of 5 genes against the position
on the genome (average position for the 5 genes). We then
manually inspected the graphs for all 14 Toxoplasma chromosomes
for each of the 29 strains for large genomic regions (.0.2 Mb)
where a strain had more than 1.5 times the median expression
value.
Luciferase assay
HEK293 cells stably expressing a luciferase gene under the
control of four consecutive NFkB consensus promoter elements
(Systems Biosciences) were infected with the indicated strains of
Toxoplasma gondii in 3 MOIs (2.5, 5, 10). At 20 hpi culture
supernatants were collected and cells were lysed. Luciferase
activity was measured in the lysates using Promega’s Luciferase
Assay System.
Western blotting
Rabbit polyclonal antibodies to GRA15 were raised against the
peptide with the amino acid sequence of GRA15493–510
(CGPPRTENPRQPQVPGENS) and affinity purified with the
antigen (YenZym Antibody, San Francisco, CA). 2.56106
parasites were harvested from T25 flasks with infected HFFs,
lysed by addition of lysis buffer, boiled for 5 minutes, placed at
4uC for 5 minutes and centrifuged at 13,000 rpm at 4uC for
15 minutes. Lysates were run on 10% SDS-PAGE protein gel,
transferred to a polyvinylidene difluoride membrane and blocked
in PBS/0.1% Tween-20/5% nonfat dry milk. The blot was then
incubated with primary polyclonal anti-rabbit GRA15 antibodies
overnight at room temperature using 1 ug/mL, followed by
secondary goat anti-rabbit horseradish peroxidase antibody for
1 hour at room temperature. The blot was then incubated with a
luminal based substrate (Immun-Star WesternC, Bio-Rad Labo-
ratories) and chemiluminescence was detected using a charge-
coupled device camera (Chemidoc XRS, Bio-Rad Laboratories).
Bands were visualized using Quantity One 1-D analysis software.
Immunofluorescence assays
HFFs seeded on coverslips were infected with T. gondii and
incubated for different time points. Cells were then fixed with 4%
formaldehyde in PBS for 20 min at room temperature, permea-
bilized and blocked with phosphate-buffered saline (PBS) plus 5%
goat serum, 3% serum bovine albumin and 0.2% Triton X-100.
Subsequently coverslips were incubated with primary antibody
overnight at 4uC, washed twice with PBS, and incubated with
fluorescent secondary antibodies and Hoechst to allow visualiza-
tion of antigen and DNA respectively. Coverslips were mounted
on a glass slide with Vectashield (VectorLaboratories). Photo-
graphs were taken using NIS-Elements software (Nikon) and a
digital camera (CoolSNAP EZ; Roper Industries) connected to an
inverted fluorescence microscope (model eclipse Ti-S; Nikon).
Cytokine production
Cell culture supernatants were assayed for cytokines with
DuoSet ELISA kits from R&D Systems according to the
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manufacturer’s instructions. IFNb was quantified from cell culture
supernatants using a custom ELISA as described elsewhere [82].
Quantitative PCR
Cells were infected with the indicated strains of Toxoplasma gondii
or transfected with parasite DNA using either Xtreme-GENE9 or
DOTAP (Roche) transfection reagents according to manufacturer
instructions. Eight to 20 hours post infection cells were lysed, total
RNA was extracted using the RNeasy Plus kit (Qiagen), and
quantified using a NanoDrop spectrophotometer (Thermo Scien-
tific). cDNA was synthetized using the SuperScript III First Strand
Synthesis System (Invitrogen), and RT-PCR analysis was per-
formed in a Light Cycler 480 II Real-time PCR machine (Roche)
using the SYBR Green I Master kit (Roche) according to the
manufacturer’s instructions. Primers used are as follows: mIFNb-
Fw: ATAAGCAGCTCCAGCTCCAA; mIFNb-Rv: CTGTC-
TGCTGGTGGAGTTCA; mRsad2-Fw: AACCCCCGTGAG-
TGTCAACTA; mRsad2-Rv: AACCAGCCTGTTTGAGCAG-
AA; mActin-Fw: TTGAACATGGCATTGTTACCAA; mActin-
Rv: TGGCATAGAGGTCTTTACGGA.
Microarrays
Human foreskin fibroblasts grown to confluency into T25 flasks
were infected with the indicated strains of T. gondii at 3 different
MOIs. At 24 h post infection total RNA was isolated using Trizol
(Invitrogen) and cleaned up using RNeasy MinElute kit (Qiagen)
following manufacturer’s protocols. Subsequently RNA was
labeled, hybridized to a human Affymetrix array (Human
U133A 2.0) and processed as described elsewhere [32].
Parasite growth
Monolayers of HFFs grown on coverslips were infected with the
type II (PA7) strain or COUGAR, fixed at different time points
and stained with antibodies against GRA7 and SAG1. Parasite
vacuoles (GRA7 positive) per field and the number of parasites per
vacuole (SAG1 staining) were counted.
Accession numbers
The sequences reported in this paper have been deposited in
Short Read Archive, http://www.ncbi.nlm.nih.gov/sra (accession
Nos. SRP008923 and SRP011061)
Supporting Information
Figure S1 Toxoplasma induced macrophage gene
expression analysis by RNAseq correlates well with
microarray analysis but is more sensitive. Venn
diagram depicting number of genes that were upregulated at
least 1.6 fold upon infection of BMDMs with ME49 strain
when compared to non-infected cells, detected by either
microarray or RNA sequencing. Pearson analysis of ranked
expression values of host cell protein coding genes from
samples infected with ME49 strain obtained using either
microarray or RNA sequencing showed a correlation of 0.88
demonstrating that RNAseq and microarray results are
comparable.
(TIF)
Figure S2 Transcriptome analysis of host cells infected
with 29 Toxoplasma strains reveals clusters of co-
regulated genes enriched in functional annotation.
Representative heat maps are shown of differentially expressed
mouse gene clusters. Results of the analysis of enrichment in
functional annotation using DiRE, GSEA, and Ingenuity Pathway
Analysis are shown.
(TIF)
Figure S3 Clusters of co-regulated Toxoplasma genes
identified by transcriptome analysis. Representative heat
maps are shown of differentially expressed Toxoplasma gene
clusters. Results of the analysis of enrichment in functional
annotation using DiRE, GSEA, and Ingenuity Pathway Analysis
are shown.
(TIF)
Figure S4 Evolutionary bootstrap consensus tree of
GRA15. The tree was inferred from 500 replicates using the
Neighbor-Joining method. The percentages of replicate trees in
which the associated taxa clustered together in the bootstrap test
(500 replicates) are shown next to the branches. The tree is drawn
to scale, with branch lengths in the same units as those of the
evolutionary distances used to infer the phylogenetic tree. The
evolutionary distances were computed using the Poisson correction
method and are in the units of the number of amino acid
substitutions per site. Analyses were performed in MEGA5
software.
(TIF)
Figure S5 Alignment of GRA15 predicted protein se-
quences from different Toxoplasma strains. The amino
acid sequences were predicted from nucleotide sequences obtained
by PCR sequencing, and the multiple sequence alignment was
performed using the MacVector Software (vs12.6, Accelrys, Cary,
NC, USA). Identical (.) and missing (-) aminoacids are indicated.
(TIF)
Figure S6 Alleles of GRA15 differ in their ability to
induce nuclear translocation of NFkB. Human foreskin
fibroblasts were infected with the indicated strains of Toxoplasma
for 16 hours, fixed, and stained with a-NFkB (p65, red), a-SAG1
(green) and Hoechst (blue). Nuclear translocation of p65 was only
observed in cells infected with parasites expressing the type II allele
of GRA15.
(TIF)
Figure S7 Alignment of ROP16 predicted protein se-
quences from different Toxoplasma strains. The amino
acid sequences were predicted from nucleotide sequences obtained
by PCR sequencing, and the multiple sequence alignment was
performed using the MacVector Software (vs12.6, Accelrys, Cary,
NC, USA). Identical (.) and missing (-) aminoacids are indicated.
(TIF)
Figure S8 Sustained nuclear translocation of STAT6 can
be achieved by either type I or atypical alleles of ROP16,
but not by the type II allele. Human foreskin fibroblasts were
infected with the indicated strains of Toxoplasma for 16 hours,
fixed, and stained with a-SAG1 (green), Hoechst (blue) and either
a-phosphorylated STAT6 (red). Canonical types I and III
parasites and all atypical strains tested, but not type II parasites,
induced sustained nulcear translocation of STAT6. Type I
parasites knockout out for ROP16I loose their ability to activate
STAT6, whereas Type II parasites overexpressing ROP16I
acquire the ability to do so.
(TIF)
Figure S9 Sustained nuclear translocation of STAT5 can
be achieved by either type I or atypical alleles of ROP16,
but not by the type II allele. Human foreskin fibroblasts were
infected with the indicated strains of Toxoplasma for 16 hours,
fixed, and stained with a-SAG1 (green), Hoechst (blue) and either
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a-phosphorylated STAT5 (red). Canonical types I and III
parasites and all atypical strains tested, but not type II parasites,
induced sustained nulcear translocation of STAT5. Type I
parasites knockout out for ROP16I loose their ability to activate
STAT5, whereas Type II parasites overexpressing ROP16I
acquire the ability to do so.
(TIF)
Figure S10 Type I interferon prodution induced by
double stranded DNA is dependent on RIG-I. Synthetic
double stranded DNA poly d(A):d(T) was transfected into
immortalized macrophages either wild type or knockout for the
indicated genes using XtremeGENE9. Cells were incubated
overnight, subsequently total RNA was extracted and qPCR was
performed to detect Ifnb1. Relative expression levels were
calculated by normalizing against actin expression.
(TIF)
Figure S11 RNA profile of Toxoplasma-infected bone-
marrow derived macrophages. Bone marrow-derived mac-
rophages either non-infected or infected with three different MOIs
for 20 h with the indicated strains were lysed, and cells extracts
subjected to total RNA isolation using Qiagen RNeasy Plus kit.
Integrity, sizing, quality and quantification of RNA was then
performed using the Agilent 2100 Bioanalyser, and examples of
the pseudo gel image created for a non-infected (NI) or infected
(GUYDOS, VAND and COUGAR) samples are shown. Only
samples with equivalent amounts of parasite-derived RNA were
used for RNA sequencing.
(TIF)
Protocol S1 Detailed protocol used for RNA sequencing
and expression profiling of Toxoplasma gondii and
infected host cells.
(DOC)
Table S1 Expression values for all Toxoplasma and
mouse genes. FPKM values for Toxoplasma and mouse genes for
each of the samples infected with one of the 29 different Toxoplasma
strains are indicated. Also the position of each gene in each of the
co-regulated Toxoplasma or mouse gene expression clusters is
indicated. Potential Toxoplasma or host gene expression regulators
are also indicated.
(TXT)
Table S2 Pair-wise Pearson correlations between aver-
age expression values of the mouse and Toxoplasma
gene expression clusters.
(XLS)
Table S3 Parameters used running Tophat and Cuf-
flinks to obtain FPKM values for (A) mouse or (B)
Toxoplasma genes.
(XLS)
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